Accessing treatment in Australia
What it takes for a treatment to reach you here, in plain English. What PBS listing means, the PBS Safety Net, how the Special Access Scheme works, what a shortage report means, and the questions worth raising with your doctor. Not medical advice.
A treatment being approved overseas, or even approved in Australia, is not the same as you being able to get it affordably here. This page explains the parts of the Australian system that decide that. It is a general explainer, not a lookup tool, and it cannot tell you whether a specific medicine is available for your situation. Only your doctor can work that out with you. If this feels like a lot to take in, that is a fair reaction. The system genuinely has several separate moving parts, and this page exists to lay them out clearly, not to make you feel you should already understand them.
New to Voxsanity? See how drug research reaches patients, the five stages from research funding to PBS listing, and where the access step below fits into the whole picture.
Recent PBS listing changes
Real changes to what is subsidised, tracked as the PBS schedule updates, so you do not have to go looking for them.
Drawn from the PBS Schedule and its published summary of changes at build time. The PBS Schedule is updated monthly. A medicine counts as newly subsidised only when its first listing date is this Schedule's effective date, and as removed only when it no longer appears in the Schedule at all, so a routine change to one pack size or brand is never reported as a listing or a removal. The three categories cannot overlap, so they add up to the total above. The list is a sample: newly subsidised medicines appear only where their PBS restriction maps to a condition Voxsanity tracks, and removed medicines are no longer in the Schedule, so no condition can be shown for them. See the full month's changes →
What "listed on the PBS" actually means
The Pharmaceutical Benefits Scheme, or PBS, is the Australian Government scheme that subsidises the cost of many medicines. When a medicine is listed on the PBS for a use, the government pays most of the cost and the patient pays a capped co-payment, $25.00 for general patients in 2026, with concession cardholders paying a lower amount. Your pharmacist can confirm what you will pay. A medicine can be approved for use in Australia and still not be on the PBS, which is often where a large out of pocket cost comes from.
When Voxsanity shows a PBS status for a medicine, here is what each status means.
- Listed. A medicine is listed on the PBS, according to the Pharmaceutical Benefits Scheme, so its cost is subsidised. Your doctor can advise whether a PBS subsidised option is appropriate for you.
- Decision in progress. A PBS listing decision is currently in progress, according to the Pharmaceutical Benefits Scheme. Listing status can change, and access before listing may still be possible through other pathways your doctor can explain.
- Registered but not listed. A medicine is registered for use but not currently listed on the PBS, according to the Pharmaceutical Benefits Scheme. This can mean higher out of pocket cost. Your doctor can explain the available access pathways.
- Listing changed. A medicine has changed its PBS listing status, according to the Pharmaceutical Benefits Scheme. Your doctor or pharmacist can advise on current availability and alternatives.
How many conditions we track have a PBS-subsidised option
63 of 103 conditions Voxsanity tracks have at least one PBS-subsidised medicine mapped to them today, each mapping individually reviewed, not automatically matched. The rest show an honest "none currently mapped" line rather than a guess.
See this broken down on the Insights page →
The PBS Safety Net
Once your PBS costs (or your family's, if you register as a family) reach a set threshold within a calendar year, the Safety Net kicks in.
The exact threshold is set each year and differs for concession and general patients, so this page does not quote a figure that could go out of date. Every PBS prescription counts toward it. Your pharmacist can usually tell you on the spot how close you are, and Services Australia publishes the current thresholds.
The Special Access Scheme and its pathways
The Special Access Scheme, or SAS, is the way a doctor can arrange a medicine that is not otherwise approved for general supply in Australia. There are three SAS pathways, plus a separate Authorised Prescriber arrangement. Which one applies depends on how urgent the situation is and whether the medicine is already on a government list. All of them are actioned by a medical practitioner, not by the patient.
Category A
This pathway is for people who are seriously ill. A doctor can arrange the medicine straight away and then tells the TGA afterwards. It is meant for urgent situations where waiting for approval would put the person at serious risk. Only a medical practitioner can use this pathway.
Category B
This pathway is an application. The doctor sends a request to the TGA and waits for a decision before the medicine can be supplied. It is used when the situation does not fit Category A and the medicine is not on the Category C list. The TGA looks at each request on its own facts.
Category C
This pathway is built around a published list. The government keeps a list of medicines that have a well understood history of use for certain purposes. When a medicine and its use are on that list, an approved type of health practitioner can supply it and then notify the TGA, without waiting for approval first. It only covers the exact medicines and uses named on the list.
Authorised Prescriber
Separate from the three SAS pathways, the TGA can authorise a specific doctor to prescribe a specific unapproved medicine to patients in their care with a particular condition. This is called being an Authorised Prescriber. Once it is granted, that doctor can prescribe the medicine to eligible patients without a separate application each time. Whether this arrangement applies is a decision for the doctor and the TGA.
Only a registered Australian medical practitioner can apply for or notify SAS access on your behalf. This page describes how these pathways work in general. It does not tell you whether a specific medicine is accessible for a specific condition. Always speak to your doctor about your specific situation. For a fuller walk through of the SAS pathways, see the Special Access Scheme explainer.
What a shortage report means, and what it does not
A shortage report means the TGA has been told that the supply of a medicine is, or will be, lower than the expected demand for a period. It does not mean the medicine is gone, and it does not always affect everyone. Shortages often affect some brands or strengths but not others. If a medicine you take is in short supply, speak to your pharmacist, who can advise on availability and alternatives. Do not change how you take your medicine without speaking to your doctor or pharmacist. Where an expected resolution date has been reported, the TGA shows that date against the shortage in its own database.
This section explains what a shortage report is. Voxsanity does not publish shortage records and does not currently offer a shortage lookup, so nothing on this page tells you whether any particular medicine is in short supply. To check a specific medicine, use the TGA's own Medicine Shortage Reports Database, or ask your pharmacist.
Private prescriptions and compassionate access
A private prescription is a prescription for a medicine that is not subsidised on the PBS for that use. The medicine may still be approved and available, but because the PBS does not cover it, the price is set privately and is usually higher. Your pharmacist can confirm what you will pay.
Some manufacturers run compassionate access or early access programs that provide a medicine at reduced or no cost to patients who meet criteria the manufacturer sets, sometimes before or around the time of approval. These programs are run by the manufacturer rather than the government, and a doctor arranges them. What is available changes over time, so this is a question for your doctor.
Questions you could ask your doctor
If treatment access is on your mind, these are some questions you could raise at an appointment. They are suggestions to help start a conversation, not instructions, and the answers depend on your specific situation.
- Is there a medicine for my condition that is listed on the PBS, and would it suit my situation?
- If a medicine is not on the PBS, is there a Special Access Scheme or Authorised Prescriber pathway that could be relevant?
- If a medicine I take is in short supply, is there a suitable alternative brand or strength?
- What would a private prescription for this medicine involve, and roughly what would it cost?
- Are there any clinical trials recruiting in Australia that might be worth me looking into?
Where to go next
Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.
Not medical advice. Information on this site does not constitute medical advice. Data is sourced from publicly available government registries. Always consult your doctor before making any health decisions. Trial status should be verified directly with the trial site.